147 related articles for article (PubMed ID: 2717786)
1. Preliminary estimates of the virtually safe dose for tumors obtained from the maximum tolerated dose.
Gaylor DW
Regul Toxicol Pharmacol; 1989 Apr; 9(2):101-8. PubMed ID: 2717786
[TBL] [Abstract][Full Text] [Related]
2. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
3. Regulatory cancer risk assessment based on a quick estimate of a benchmark dose derived from the maximum tolerated dose.
Gaylor DW; Swirsky Gold L
Regul Toxicol Pharmacol; 1998 Dec; 28(3):222-5. PubMed ID: 10049793
[TBL] [Abstract][Full Text] [Related]
4. Quick estimate of the regulatory virtually safe dose based on the maximum tolerated dose for rodent bioassays.
Gaylor DW; Gold LS
Regul Toxicol Pharmacol; 1995 Aug; 22(1):57-63. PubMed ID: 7494904
[TBL] [Abstract][Full Text] [Related]
5. An examination of the association between maximum-tolerated dose and carcinogenicity in 326 long-term studies in rats and mice.
Haseman JK; Seilkop SK
Fundam Appl Toxicol; 1992 Aug; 19(2):207-13. PubMed ID: 1516777
[TBL] [Abstract][Full Text] [Related]
6. Experimental design constraints on carcinogenic potency estimates.
Rieth JP; Starr TB
J Toxicol Environ Health; 1989; 27(3):287-96. PubMed ID: 2754755
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological and experimental applications to occupational cancer prevention.
Vainio H; Hemminki K
J UOEH; 1989 Mar; 11 Suppl():323-45. PubMed ID: 2664947
[TBL] [Abstract][Full Text] [Related]
8. The relationship between use of the maximum tolerated dose and study sensitivity for detecting rodent carcinogenicity.
Haseman JK; Lockhart A
Fundam Appl Toxicol; 1994 Apr; 22(3):382-91. PubMed ID: 8050633
[TBL] [Abstract][Full Text] [Related]
9. An overview of the report: correlation between carcinogenic potency and the maximum tolerated dose: implications for risk assessment.
Krewski D; Gaylor DW; Soms AP; Szyszkowicz M
Risk Anal; 1993 Aug; 13(4):383-98. PubMed ID: 8234946
[TBL] [Abstract][Full Text] [Related]
10. Carcinogenic risk assessment: comparison of estimated safe doses for rats and mice.
Chen JJ; Gaylor DW
Environ Health Perspect; 1987 Jun; 72():305-9. PubMed ID: 3622439
[TBL] [Abstract][Full Text] [Related]
11. Predicting the carcinogenicity of chemicals in humans from rodent bioassay data.
Goodman G; Wilson R
Environ Health Perspect; 1991 Aug; 94():195-218. PubMed ID: 1954931
[TBL] [Abstract][Full Text] [Related]
12. Structural relationships between mutagenicity, maximum tolerated dose, and carcinogenicity in rodents.
Rosenkranz HS; Klopman G
Environ Mol Mutagen; 1993; 21(2):193-206. PubMed ID: 8444146
[TBL] [Abstract][Full Text] [Related]
13. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 1/2. A multi-factor ranking scheme for comparing the carcinogenic activity of chemicals.
Nesnow S
Mutat Res; 1990 Sep; 239(2):83-115. PubMed ID: 2385240
[TBL] [Abstract][Full Text] [Related]
14. Issues in carcinogenicity testing: dose selection.
Haseman JK
Fundam Appl Toxicol; 1985 Feb; 5(1):66-78. PubMed ID: 3886467
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the utility of the lifetime mouse bioassay in the identification of cancer hazards for humans.
Osimitz TG; Droege W; Boobis AR; Lake BG
Food Chem Toxicol; 2013 Oct; 60():550-62. PubMed ID: 23954551
[TBL] [Abstract][Full Text] [Related]
16. A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments.
Butterworth BE; Conolly RB; Morgan KT
Cancer Lett; 1995 Jun; 93(1):129-46. PubMed ID: 7600540
[TBL] [Abstract][Full Text] [Related]
17. Decreased electrophilicity of chemicals carcinogenic only at the maximum tolerated dose.
Rosenkranz HS; Klopman G
Mutat Res; 1992 Aug; 282(4):241-6. PubMed ID: 1379685
[TBL] [Abstract][Full Text] [Related]
18. Prediction of carcinogenicity from two versus four sex-species groups in the carcinogenic potency database.
Gold LS; Slone TH
J Toxicol Environ Health; 1993 May; 39(1):143-57. PubMed ID: 8492327
[TBL] [Abstract][Full Text] [Related]
19. An appreciation of the maximum tolerated dose: an inadequately precise decision point in designing a carcinogenesis bioassay?
Clayson DB; Iverson F; Mueller R
Teratog Carcinog Mutagen; 1991; 11(6):279-96. PubMed ID: 1687837
[TBL] [Abstract][Full Text] [Related]
20. A critique of the use of the maximum tolerated dose in bioassays to assess cancer risks from chemicals.
Carr CJ; Kolbye AC
Regul Toxicol Pharmacol; 1991 Aug; 14(1):78-87. PubMed ID: 1947247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
